SMART M195: Began Phase II/III trial

Protein Design Labs Inc. (PDLI), Mountain View, Calif. Product: SMART M195 humanized antibody, which targets the CD33 antigen on myeloid leukemia cells Indication: Acute myeloid leukemia in remission...